2m 2m 2m 2m 2m 2m 2m
MBX BIO (MBX)
NASDAQ
$55.44-$2.28 (-3.95%)
Price as of Nov 12, 2026 10:02 AM EST- $2.8BMarket Cap
- 134.63%1-Year Change
- BiotechnologyIndustry
MBX BIO (MBX)
$55.44-$2.28 (-3.95%)
MBX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $57.72 | ||
Change | +$1.39 (+2.47%) | ||
Open | $56.33 | ||
High | $58.56 | ||
Low | $55.25 | ||
Previous Close | $56.33 | ||
Volume | 556,665 | ||
30-Day Average Volume | 597,871 | ||
1-Week Change | 9.98% | ||
1-Month Change | 8.41% | ||
1-Year Change | 134.63% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 48.2M | ||
Total Assets | $500.6M | ||
Market Cap | $2.8B | ||
Enterprise Value | $2.6B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$62.4M | ||
Free Cash Flow | -$36.1M | ||
EBIT | -$62.4M | ||
EBITDA | -$62.3M | ||
Net Working Capital | $467.6M | ||
EPS | -$1.29 | ||
Enterprise Value/EBITDA | -42 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 6 | ||
P/E | -45 | ||
PEG | 1 | ||
Price/Free Cash Flow | -77 | ||
Price/Operating Cash Flow | -80 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue